Monday - December 23, 2024

Method of Treating Patients With a Mutation in Cyclin-Dependent Kinase-Like 5 (CDKL5)

2024-11-19

ALEXANDRIA, Virginia, Nov. 19 -- ZOGENIX INTERNATIONAL LIMITED, Berkshire, United Kingdom has been assigned a patent (No. US 12144787 B2, initially filed Nov. 22, 2019) developed by Bradley S. Galer, West Chester, Pennsylvania, and Bret Megargel, San Diego, California, for "Method of treating patients with a mutation in cyclin-dependent kinase-like 5 (CDKL5)." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Method of Treating Patients With a Mutation in Cyclin-Dependent Kinase-Like 5 (CDKL5)

Information Request Form

Copyright Targeted News Service 2024